Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 7Gliosarcoma 5Glioblastoma 5Brain Neoplasms 4Small Cell Lung Carcinoma 3Oligodendroglioma 3Astrocytoma 3Pancreatic Neoplasms 2Osteosarcoma 2Meningioma 2Medulloblastoma 2Lymphoma 2Lung Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Glioma 2Colorectal Neoplasms 2Colonic Neoplasms 2Choroid Plexus Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Wilms Tumor 1Uterine Neoplasms 1Sarcoma, Myeloid 1Sarcoma, Kaposi 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Pinealoma 1

Interventions

liposomal doxorubicin 3Paclitaxel 3Thalidomide 2Semaxinib 2Polymerase Chain Reaction 2Filgrastim 2Etoposide 2Docetaxel 2Daunorubicin 2valspodar 1nirogacestat 1halofuginone 1etoposide phosphate 1entinostat 1emvododstat 1efineptakin alfa 1Valproic Acid 1Sunitinib 1Sirolimus 1Saquinavir 1SUB1 protein, human 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Palliative Care 1Nutritional Support 1Nelfinavir 1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3- dimethyl-L-Valinamide 1Lenalidomide 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × Bortezomib × Sarcoma × Clear all
NCT01016730 2018-02-20

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡